| Literature DB >> 35341112 |
Smita Chandra1, Anuradha Kusum1, Dushyant Singh Gaur1, Harish Chandra2.
Abstract
Objective: Analytical and post analytical phase are integral part of total quality management system and include steps from submission of slides till reports are dispatched. The present study was conducted to analyze the analytical and post analytical phase of the ISO15189:2012 certified cytopathology laboratory. It was also intended to study the various errors which were encountered and steps taken to reduce these discrepancies.Entities:
Keywords: Analytical phase; cytopathology; post analytical phase; quality management
Year: 2022 PMID: 35341112 PMCID: PMC8955700 DOI: 10.4103/JOC.JOC_90_20
Source DB: PubMed Journal: J Cytol ISSN: 0970-9371 Impact factor: 1.000
List of documents in the analytical and post analytical phase at cytopathology laboratory
| Reporting documents | Cytotechnician/PG screening format |
| Quality control records | Internal quality control records |
| Reporting records | Papanicolaou smear correlation record |
| Post analytical phase records | Typographical error record |
| Other records | Slide issue and storage record |
Total samples reported in the cytopathology laboratory in the last 5 years
| Types of samples | Number of samples |
|---|---|
| Cervico-vaginal Pap smears | 7408 (34.35) |
| Body Fluids | |
| CSF | 121 (0.56) |
| Pleural | 720 (3.33) |
| Ascitic | 901 (4.17) |
| Pericardial | 35 (0.16) |
| Synovial | 80 (0.37) |
| Semen | 431 (1.99) |
| Broncho-alveolar lavage | 261 (1.21) |
| FNAC | |
| Image guided FNAC | 2015 (9.34) |
| Direct FNAC | 7721 (35.80) |
| Exfoliate cytology (Non Gynecological) | 1001 (4.64) |
| Nipple discharge | 247 (1.14) |
| Bronchial brush | 458 (2.12) |
| Esophageal brush | 84 (0.38) |
| Sputum | 122 (0.56) |
| Skin | 90 (0.41) |
| Review slides and others | 872 (4.04) |
| Total | 21,566 |
Analytical and post analytical errors detected in the cytopathology laboratory with the corrective action
| Types of Error | Number of errors (%) | Corrective Action Taken |
|---|---|---|
| Analytical errors | ||
| Screening error | 21 (4.1) | Training |
| Internal quality control error in diagnosis | 6 (1.1) | Use of universally approved system of reporting, training and reporting by experienced cytopathologists |
| External quality control error in diagnosis | 3 (0.5) | Root cause analysis with training |
| Cyto-histopathological discrepancy in non-gynecological lesions due to interpretation | 57 (11.3) | Training with complete clinical, radiological information and good communication with clinician |
| ASCUS: SIL ratio error | 7 (1.38) | Training and adequate clinical information |
| Cyto-histopathological discrepancy in gynecological lesions | 24 (4.7) | Training through workshops, seminars with clinical and colposcopic information. Obtaining of adequate diagnostic material |
| Post-Analytical errors | ||
| Typographical error | 201 (39.8) | Use of reporting templates, training of new typists to become acquainted with scientific terms, re-checking of typed reports, reducing typing overload |
| Delay in reporting with increased TAT | 148 (29.3) | Urgent reporting parameters to be highlighted with continuous monitoring on hospital information system, stamping the time of submission of slides or reports for reporting and typing on the requisition form |
| Alert report or advisory not informed to clinician or patient | 37 (7.3) | Training |
Cyto-histopathological discordance in gynecological cases
| Cytological diagnosis | Discordant histopathological diagnosis | Number of cases |
|---|---|---|
| Atypical cells of undetermined significance (ASC-US) | Cervical intraepithelial neoplasia (CIN) 1 | 3 |
| Cervical intraepithelial neoplasia (CIN) 2 | 4 | |
| Low grade squamous intraepithelial lesion (LSIL) | Cervical intraepithelial neoplasia (CIN) 2 | 2 |
| Cervical intraepithelial neoplasia (CIN) 3 | 2 | |
| High grade squamous intraepithelial lesion (HSIL) | Cervical intraepithelial neoplasia (CIN) 2 | 4 |
| Squamous cell carcinoma (SCC) | 4 | |
| Atypical glandular cells, favour neoplastic | Endometrial polyp | 2 |
| Invasive carcinoma | Cervical intraepithelial neoplasia (CIN) 3 | 3 |
Cyto-histopathological discordance in non-gynecological cases
| Cytologicaldiagnosis | Discordant histopathological diagnosis | Number of cases |
|---|---|---|
| Pulmonary lesion | ||
| Granulomatous inflammation | Negative for granuloma | 2 |
| Negative for malignancy | Broncho-alveolar carcinoma | 1 |
| Atypical cells favoring reactive changes | Squamous cell carcinoma | 2 |
| Inadequate | Squamous cell carcinoma | 2 |
| Negative for malignancy | 3 | |
| Granulomatous inflammation | 3 | |
| Adenocarcinoma | 2 | |
| Thyroid | ||
| Colloid goitre | Follicular adenoma | 1 |
| Atypia of undetermined significance/Follicular lesion of undetermined significance | Papillary carcinoma | 3 |
| Inadequate | Papillary carcinoma | 1 |
| Colloid goitre | 2 | |
| Papillary carcinoma | 2 | |
| Breast | ||
| Atypical epitheliosis | Infiltrating ductal carcinoma | 3 |
| Ductal carcinoma | Atypical ductal hyperplasia | 1 |
| Mucinous carcinoma | Lobular carcinoma | 3 |
| Infiltrating ductal carcinoma with mucinous change | 2 | |
| Lymph node | ||
| Reactive hyperplasia | Histoplasmosis | 1 |
| Hodgkin’s Lymphoma | Hodgkin’s lymphoma | 1 |
| Non Hodgkin’s lymphoma-Mantle cell type | 1 | |
| Reactive lymphadenitis (Viral induced) | 1 | |
| Hepato-biliary lesions | ||
| Liver-Metastatic adenocarcinoma | Hepatocellular carcinoma | 1 |
| Gall Bladder-Adenocarcinoma | Xnthogranulomatouscholecystitis | 1 |
| Soft tissue | ||
| Lipoma | Well differentiated liposarcoma | 1 |
| Neurofibroma | Schwannoma | 1 |
| Salivary gland | ||
| Chronic sialadenitis | Warthin’s tumor | 2 |
| Pleomorphic adenoma | Pleomorphic adenoma ex carcinoma | 1 |
| Inadequate | Warthin’s tumor | 1 |
| Bone | ||
| Aneurysmal bone cyst | Giant cell tumor | 1 |
| Inadequate | Osteosarcoma | 1 |
| Serous Fluids | ||
| Pleural Fluid | Pulmonary adenocarcinoma | 2 |
| Inadequate | Negative for malignancy | 1 |
| Negative for malignancy (1) | Positive for lung adenocarcinoma | 2 |
| Atypical cell favoring reactive (1) | Omental deposits of ovarian mucinous adenocarcinoma | 1 |
| Ascitic fluid | Negative for gall bladder carcinoma | 2 |
| Negative for carcinoma | ||
| Atypical cells favoring malignancy |